Given the overlapping pathophysiological mechanisms shared by PAD and cardiac disease, including endothelial dysfunction, metabolic dysregulation, and atherosclerosis [10], there is important value in investigating GDF15’s prognostic utility in patients with PAD. Here, GDF15 is linked to peripheral arterial disease.